Friday, August 21, 2020 10:42:30 PM
Recent XRTX News
- XORTX Announces New Clinical Advisory Board Member • GlobeNewswire Inc. • 03/27/2024 09:00:00 AM
- XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial • GlobeNewswire Inc. • 03/19/2024 09:00:00 AM
- XORTX Reprices Warrants Issued in Connection with Previous Private Placements • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units • GlobeNewswire Inc. • 03/04/2024 12:00:00 PM
- XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of Units • GlobeNewswire Inc. • 02/15/2024 12:00:00 PM
- XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units • GlobeNewswire Inc. • 02/02/2024 01:46:09 AM
- XORTX Announces $2 Million Public Offering • GlobeNewswire Inc. • 01/15/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/03/2024 12:25:58 PM
- XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/02/2024 01:12:44 PM
- XORTX Welcomes New Member to the Board of Directors • GlobeNewswire Inc. • 01/02/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/30/2023 09:04:02 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/30/2023 12:30:05 PM
- XORTX Announces US ATM Offering • GlobeNewswire Inc. • 11/30/2023 12:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/30/2023 02:57:42 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/29/2023 12:00:05 PM
- XORTX Meets Nasdaq Continued Listing Requirements • GlobeNewswire Inc. • 11/29/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 12:00:11 PM
- XORTX Clarifies Timing for Share Consolidation • GlobeNewswire Inc. • 11/10/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2023 10:00:08 PM
- XORTX Announces Share Consolidation • GlobeNewswire Inc. • 11/08/2023 10:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/02/2023 11:00:12 AM
- XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023 • GlobeNewswire Inc. • 11/02/2023 11:00:00 AM
- XORTX Announces Results of Special Meeting of Shareholders • GlobeNewswire Inc. • 10/27/2023 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/25/2023 09:00:06 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM